HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in
Andrea P Malizia1, Eoin Cotter, Nicholas Chew
1General Clinical Research Unit, Mater Misericordiae University Hospital, School of Medicine and Medical Sciences, University College Dublin, 44 Eccles Street, Dublin 7, Ireland.
Abstract:
HIV-infected patients are at increased risk of decreased bone mineral density. Some studies have implicated antiretroviral therapy as a contributor to the decreased bone mineral density seen in treated HIV-1 patients. In this study we explore the interactions between protease inhibitors (PI) and primary human osteoblast gene expression, highlighting a group of dysregulated genes that potentially are key factors in reducing bone formation. Runx-2 mRNA expression, calcium deposition, and alkaline phosphatase (ALP) activity decreased significantly in human osteoblast cultures after exposure to the PIs nelfinavir (NFV) and indinavir (IDV). Saquinavir (SQV), ritonavir (RTV), indinavir (IDV), or nelfinavir (NFV) exposure induced significant changes in genotypic expression as assessed by gene-chip microarray analysis. The altered genes from each group were compared to each other and a list of 8 upregulated and 13 downregulated genes only after NFV and IDV exposure was identified. This set includes TIMP-3, which has previously been demonstrated to be involved in osteoblast differentiation and extracellular matrix development processes. Silencing TIMP-3 mRNA expression using siRNA duplexes enhanced calcium deposition and ALP activity significantly, even after exposure to NFV and IDV. Our data suggest a link between reduced osteoblastic phenotype and a group of 21 altered genes following NFV and IDV treatment, and also suggest TIMP-3 may be involved in the PI-induced inhibition of osteoblast function.
Insights
Protease inhibitors (PIs) used to treat HIV-1 can harm bone health. This study found that nelfinavir and indinavir alter osteoblast gene expression, potentially explaining reduced bone formation and identifying TIMP-3 as a key factor.
Area of Science:
- Bone biology
- Virology
- Pharmacology
Background:
- HIV-infected patients exhibit reduced bone mineral density.
- Antiretroviral therapy, particularly protease inhibitors (PIs), is suspected to contribute to bone loss.
Purpose of the Study:
- To investigate the effects of PIs on human osteoblast gene expression.
- To identify specific genes involved in PI-induced inhibition of bone formation.
Main Methods:
- Exposure of primary human osteoblasts to various PIs (NFV, IDV, SQV, RTV).
- Analysis of gene expression using gene-chip microarrays.
- Assessment of osteoblast function markers (Runx-2 mRNA, calcium deposition, ALP activity).
- Validation using siRNA to silence TIMP-3 expression.
Main Results:
- NFV and IDV significantly decreased Runx-2 mRNA, calcium deposition, and ALP activity.
- PI exposure induced widespread gene expression changes.
- A specific set of 21 genes (8 upregulated, 13 downregulated) were altered by NFV and IDV.
- TIMP-3 was identified among the altered genes; silencing it rescued osteoblast function.
Conclusions:
- NFV and IDV treatment are linked to a reduced osteoblastic phenotype.
- A group of 21 dysregulated genes, including TIMP-3, may mediate PI-induced inhibition of osteoblast function.
- TIMP-3 plays a significant role in PI-induced osteoblast dysfunction.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Osteoclasts in Bone Remodeling
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

